Related Experiment Video
Updated: Apr 28, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
15.9K
Calcium intervention ameliorates experimental model of multiple sclerosis.
Dariush Haghmorad1, Mohammad B Mahmoudi1, Mahmoud Mahmoudi2
1Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Oman Medical Journal
|June 18, 2014
Summary
Calcium (Ca) treatment significantly reduced the severity of experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). This intervention attenuated EAE progression by reducing brain plaques and inflammation.
Area of Science:
- Neuroimmunology
- Inflammatory Diseases
- Calcium Signaling
Background:
- Multiple sclerosis (MS) is a prevalent inflammatory central nervous system (CNS) disease.
- Experimental autoimmune encephalomyelitis (EAE) serves as a key animal model for MS research.
- Investigating novel therapeutic agents for MS is crucial.
Purpose of the Study:
- To evaluate the therapeutic potential of Calcium (Ca) in an EAE model.
- To determine if Ca administration can mitigate the effects of EAE.
Main Methods:
- EAE was induced in C57BL/6 mice using MOG35-55 peptide and pertussis toxin.
- Mice received intraperitoneal injections of Ca (30 mg/kg) every 48 hours.
- Histological analysis of brain tissue and splenocyte culture were performed 21 days post-induction.
Main Results:
- Ca treatment significantly reduced EAE severity and brain plaque formation.
- Mononuclear cell infiltration in the CNS was lower in Ca-treated mice.
- Interferon-gamma (IFN-γ) levels in splenocytes were significantly decreased in the Ca-treated group.
Conclusions:
- Calcium (Ca) intervention demonstrates efficacy in attenuating EAE progression.
- Ca may hold therapeutic promise for managing inflammatory CNS diseases like MS.
